<bill session="117" type="h" number="4432" updated="2023-03-09T17:45:31Z">
  <state datetime="2021-07-15">INTRODUCED</state>
  <status>
    <introduced datetime="2021-07-15"/>
  </status>
  <introduced datetime="2021-07-15"/>
  <titles>
    <title type="display">Department of Defense Appropriations Act, 2022</title>
    <title type="short" as="introduced">Department of Defense Appropriations Act, 2022</title>
    <title type="short" as="reported to house">Department of Defense Appropriations Act, 2022</title>
    <title type="official" as="introduced">Making appropriations for the Department of Defense for the fiscal year ending September 30, 2022, and for other purposes.</title>
  </titles>
  <sponsor bioguide_id="M001143"/>
  <cosponsors/>
  <actions>
    <action datetime="2021-07-15">
      <text>Introduced in House</text>
    </action>
    <action datetime="2021-07-15">
      <text>The House Committee on Appropriations reported an original measure, H. Rept. 117-88, by Ms. McCollum.</text>
    </action>
    <calendar datetime="2021-07-15" calendar="Union" number="63">
      <text>Placed on the Union Calendar, Calendar No. 63.</text>
    </calendar>
  </actions>
  <committees>
    <committee code="HSAP" name="House Appropriations" subcommittee="" activity="Origin, Reporting"/>
  </committees>
  <relatedbills>
    <bill session="117" type="s" number="3023" relation="unknown"/>
    <bill session="117" type="h" number="2471" relation="unknown"/>
    <bill session="117" type="h" number="256" relation="unknown"/>
    <bill session="117" type="h" number="255" relation="unknown"/>
  </relatedbills>
  <subjects>
    <term name="Armed forces and national security"/>
    <term name="Appropriations"/>
    <term name="Central Intelligence Agency (CIA)"/>
    <term name="Chemical and biological weapons"/>
    <term name="Defense spending"/>
    <term name="Department of Defense"/>
    <term name="Drug trafficking and controlled substances"/>
    <term name="Executive agency funding and structure"/>
    <term name="Government employee pay, benefits, personnel management"/>
    <term name="Intelligence activities, surveillance, classified information"/>
    <term name="Military medicine"/>
    <term name="Military personnel and dependents"/>
    <term name="Military procurement, research, weapons development"/>
    <term name="Public contracts and procurement"/>
    <term name="Research administration and funding"/>
    <term name="Research and development"/>
  </subjects>
  <amendments/>
  <summary date="2021-07-19T18:16:22Z" status="Reported to House">Department of Defense Appropriations Act, 2022

This bill provides FY2022 appropriations to the Department of Defense (DOD) for military activities.

(The bill excludes military construction, military family housing, civil works projects of the Army Corps of Engineers, and nuclear warheads, which are all considered in other appropriations bills.)

Within the DOD budget, the bill provides appropriations for

 Military Personnel; Operation and Maintenance; Procurement; Research, Development, Test and Evaluation; and Revolving and Management Funds. The bill provides appropriations for Other Department of Defense Programs, including

 the Defense Health Program, Chemical Agents and Munitions Destruction, Drug Interdiction and Counter-Drug Activities, and the Office of the Inspector General. In addition, the bill provides appropriations for Related Agencies, including (1) the Central Intelligence Agency Retirement and Disability System Fund, and (2) the Intelligence Community Management Account.

The bill also sets forth requirements and restrictions for using funds provided by this and other appropriations acts.</summary>
  <committee-reports>
    <report>H. Rept. 117-88</report>
  </committee-reports>
</bill>
